DE102004032322A1 - Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel - Google Patents

Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel Download PDF

Info

Publication number
DE102004032322A1
DE102004032322A1 DE102004032322A DE102004032322A DE102004032322A1 DE 102004032322 A1 DE102004032322 A1 DE 102004032322A1 DE 102004032322 A DE102004032322 A DE 102004032322A DE 102004032322 A DE102004032322 A DE 102004032322A DE 102004032322 A1 DE102004032322 A1 DE 102004032322A1
Authority
DE
Germany
Prior art keywords
propellant
water
aerosol suspension
propellant gas
suspension according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102004032322A
Other languages
German (de)
English (en)
Inventor
Christel Schmelzer
Arne Froemder
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boehringer Ingelheim Pharma GmbH and Co KG
Original Assignee
Boehringer Ingelheim Pharma GmbH and Co KG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma GmbH and Co KG filed Critical Boehringer Ingelheim Pharma GmbH and Co KG
Priority to DE102004032322A priority Critical patent/DE102004032322A1/de
Priority to KR1020077002760A priority patent/KR101297061B1/ko
Priority to UAA200700757A priority patent/UA89789C2/uk
Priority to AU2005259523A priority patent/AU2005259523B2/en
Priority to CNA2005800238201A priority patent/CN1984642A/zh
Priority to PCT/EP2005/006865 priority patent/WO2006002840A2/de
Priority to NZ552869A priority patent/NZ552869A/en
Priority to BRPI0512878-1A priority patent/BRPI0512878A/pt
Priority to MXPA06015204A priority patent/MXPA06015204A/es
Priority to JP2007518518A priority patent/JP5209963B2/ja
Priority to CA2571519A priority patent/CA2571519C/en
Priority to EA200700042A priority patent/EA013428B1/ru
Priority to EP05761637.7A priority patent/EP1809243B2/de
Priority to ES05761637T priority patent/ES2391563T5/es
Priority to PL05761637.7T priority patent/PL1809243T5/pl
Priority to DK05761637.7T priority patent/DK1809243T4/da
Priority to US11/169,876 priority patent/US8357352B2/en
Priority to TW094122245A priority patent/TWI377943B/zh
Priority to ARP050102757A priority patent/AR049660A1/es
Publication of DE102004032322A1 publication Critical patent/DE102004032322A1/de
Priority to ZA200609718A priority patent/ZA200609718B/xx
Priority to IL180461A priority patent/IL180461A0/en
Priority to EC2007007126A priority patent/ECSP077126A/es
Priority to NO20070373A priority patent/NO20070373L/no
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE102004032322A 2004-07-02 2004-07-02 Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel Withdrawn DE102004032322A1 (de)

Priority Applications (23)

Application Number Priority Date Filing Date Title
DE102004032322A DE102004032322A1 (de) 2004-07-02 2004-07-02 Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
EA200700042A EA013428B1 (ru) 2004-07-02 2005-06-25 РАСПЫЛЯЕМЫЕ В ВИДЕ АЭРОЗОЛЯ СУСПЕНЗИОННЫЕ КОМПОЗИЦИИ С TG 227ea ИЛИ TG 134a В КАЧЕСТВЕ ПРОПЕЛЛЕНТА
MXPA06015204A MXPA06015204A (es) 2004-07-02 2005-06-25 Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores.
AU2005259523A AU2005259523B2 (en) 2004-07-02 2005-06-25 Aerosol suspension formulations containing TG 227 ea or TG 134 a as a propellant
CNA2005800238201A CN1984642A (zh) 2004-07-02 2005-06-25 包含TG227ea或TG134a作为推进剂的气溶胶悬浮制剂
PCT/EP2005/006865 WO2006002840A2 (de) 2004-07-02 2005-06-25 Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel
NZ552869A NZ552869A (en) 2004-07-02 2005-06-25 Aerosol suspension formulations containing TG 227 ea as a propellant, an ipratropium or tiotropium salt and a small amount of free water to stabilise the composition
BRPI0512878-1A BRPI0512878A (pt) 2004-07-02 2005-06-25 formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor
UAA200700757A UA89789C2 (uk) 2004-07-02 2005-06-25 Суспензійні композиції, що розпилюються у вигляді аерозолю, з tg 227 ea або tg 134a як пропелентом
JP2007518518A JP5209963B2 (ja) 2004-07-02 2005-06-25 噴霧剤としてｔｇ２２７ｅａ又はｔｇ１３４ａを含有するエアロゾル懸濁製剤
CA2571519A CA2571519C (en) 2004-07-02 2005-06-25 Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant
KR1020077002760A KR101297061B1 (ko) 2004-07-02 2005-06-25 추진제로서 ｔｇ ２２７ ｅａ 또는 ｔｇ １３４ ａ를함유하는 에어로졸 현탁액 제형
EP05761637.7A EP1809243B2 (de) 2004-07-02 2005-06-25 Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel
DK05761637.7T DK1809243T4 (da) 2004-07-02 2005-06-25 Aerosolsuspensionsformuleringer med tg 227 ea som drivmiddel
PL05761637.7T PL1809243T5 (pl) 2004-07-02 2005-06-25 Preparaty aerozolowe w postaci zawiesin z tg 227 ea jako propelent aerozolowy
ES05761637T ES2391563T5 (es) 2004-07-02 2005-06-25 Formulaciones en suspensión de aerosol con TG 227 ea como agente propulsor
US11/169,876 US8357352B2 (en) 2004-07-02 2005-06-29 Aerosol suspension formulations containing TG 227 ea or TG 134 a as propellant
TW094122245A TWI377943B (en) 2004-07-02 2005-07-01 Aerosol suspension formulations containing tg 227 ea as propellant
ARP050102757A AR049660A1 (es) 2004-07-02 2005-07-01 Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores, usos y procedimiento de preparacion
ZA200609718A ZA200609718B (en) 2004-07-02 2006-11-22 Aerosol suspension formulations containing TG 227 EA or TG 134 A as a propellant
IL180461A IL180461A0 (en) 2004-07-02 2006-12-31 Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant
EC2007007126A ECSP077126A (es) 2004-07-02 2007-01-02 Formulaciones en suspensión de aerosol con tg 227 ea o tg 134 a como agentes propulsores
NO20070373A NO20070373L (no) 2004-07-02 2007-01-19 Aerosol suspensjonsformulering inneholdende TG 227 EA eller TG 134 A som et drivmiddel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102004032322A DE102004032322A1 (de) 2004-07-02 2004-07-02 Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel

Publications (1)

Publication Number Publication Date
DE102004032322A1 true DE102004032322A1 (de) 2006-02-09

Family

ID=35612719

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102004032322A Withdrawn DE102004032322A1 (de) 2004-07-02 2004-07-02 Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel

Country Status (4)

Country Link
CN (1) CN1984642A (uk)
DE (1) DE102004032322A1 (uk)
UA (1) UA89789C2 (uk)
ZA (1) ZA200609718B (uk)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007118802A1 (de) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel
US8357352B2 (en) 2004-07-02 2013-01-22 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing TG 227 ea or TG 134 a as propellant

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8357352B2 (en) 2004-07-02 2013-01-22 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing TG 227 ea or TG 134 a as propellant
WO2007118802A1 (de) * 2006-04-11 2007-10-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit tg 227 ea oder tg 134 a als treibmittel
US8518377B2 (en) 2006-04-11 2013-08-27 Boehringer Ingelheim Pharma Gbmh Co. Kg Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant

Also Published As

Publication number Publication date
CN1984642A (zh) 2007-06-20
ZA200609718B (en) 2008-08-27
UA89789C2 (uk) 2010-03-10

Similar Documents

Publication Publication Date Title
EP1809243B1 (de) Aerosolsuspensionsformulierungen mit tg 227 ea als treibmittel
DE68904300T2 (de) Medizinische aerosolformulierungen.
EP0514415B1 (de) Neue treibgasmischungen und ihre verwendung in arzneimittelzubereitungen
EP1100465B1 (de) Medizinische aerosolformulierungen
EP0835098B1 (de) Neue stabile arzneimittelzubereitung zur erzeugung treibgasfreier aerosole
DE69021387T2 (de) Medizinische aerosolformulierungen.
EP0630229B1 (de) Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
DE19528145A1 (de) Neue Arzneimittel und ihre Verwendung
DE4003270A1 (de) Neue treibgase und ihre verwendung in arzneimittelzubereitungen
EP0633019B1 (de) Druckgaspackungen unter Verwendung von Polyoxyethylen-glyceryl-fettsäure-estern als Suspensionsstabilisatoren und Ventilschmiermittel
EP0504112A2 (de) Pharmazeutische Aerosolformulierungen
DE19921693A1 (de) Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
EP1682542B1 (de) Neues kristallines anhydrat mit anticholinerger wirksamkeit
EP1121112A2 (de) Lagerfähiges wirkstoffkonzentrat mit formoterol
DE68919642T2 (de) Arzneimittel.
DE102012102218A1 (de) Ozon nicht abbauende medizinische Aerosolformulierungen
EP1492513B1 (de) Hfa-suspensionsformulierungen enthaltend ein anticholinergikum
DE102004032322A1 (de) Aerosolsuspensionsformulierungen mit TG 227 ea als Teibmittel
DE10214264A1 (de) HFA-Suspensionsformulierungen eines Anhydrats
DE10209243A1 (de) Neue Arzneimittelkombination zur Inhalation
DE10145438A1 (de) Neue Arzneimittel zur Inhalation

Legal Events

Date Code Title Description
R005 Application deemed withdrawn due to failure to request examination

Effective date: 20110705